VMP 42108011000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Naratriptan 2.5mg tablets
BNF code 0407041M0AAAAAA
Virtual Therapeutic Moiety Naratriptan
Date identifier became valid 28 Jul 2023
Previous product identifier 322827001
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Naratriptan hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 363571003
Strength value numerator 2.500
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Naramig 2.5mg tablets (CST Pharma Ltd)
Naramig 2.5mg tablets (GlaxoSmithKline UK Ltd)
Naramig 2.5mg tablets (Sigma Pharmaceuticals Plc)
Naratriptan 2.5mg tablets (A A H Pharmaceuticals Ltd)
Naratriptan 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Naratriptan 2.5mg tablets (CST Pharma Ltd)
Naratriptan 2.5mg tablets (Ennogen Healthcare International Ltd)
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd)
Naratriptan 2.5mg tablets (Medihealth (Northern) Ltd)
Naratriptan 2.5mg tablets (Morningside Healthcare Ltd)
Naratriptan 2.5mg tablets (Sigma Pharmaceuticals Plc)
Naratriptan 2.5mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Naratriptan 2.5mg tablets 12 tablet
Naratriptan 2.5mg tablets 2 tablet
Naratriptan 2.5mg tablets 4 tablet
Naratriptan 2.5mg tablets 6 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback